The Middle East Health Journal
SEE OTHER BRANDS

Catch up with healthcare and wellness news from the Middle East

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on April 22, 2025

Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH

Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH

VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new drug discoveries, is pleased to announce the successful …

Best Supplements for Menopause Weight Gain and Belly Fat 2025 - Top Supplement for Menopausal Weight Loss By YourBiology

Best Supplements for Menopause Weight Gain and Belly Fat 2025 - Top Supplement for Menopausal Weight Loss By YourBiology

GLASGOW, United Kingdom, April 22, 2025 (GLOBE NEWSWIRE) -- Menopause often brings challenges like stubborn belly fat, slowed metabolism, and hormonal weight gain, leaving many women frustrated. The good news? With the right combination, you can regain …

Mitolyn Reviews: Ingredients, Benefits, Pros and Cons! Honest Analysis Inside!

Mitolyn Reviews: Ingredients, Benefits, Pros and Cons! Honest Analysis Inside!

Albany, New York, April 22, 2025 (GLOBE NEWSWIRE) -- If you're struggling with stubborn weight, low energy, or slow metabolism, Mitolyn might be the breakthrough you've been waiting for. Touted as a cutting-edge mitochondrial support supplement, Mitolyn is …

Mitolyn Reviews (Investigative Warning 2025): A Comprehensive Review of the Revolutionary Mitochondrial and Cellular Health Supplement

Mitolyn Reviews (Investigative Warning 2025): A Comprehensive Review of the Revolutionary Mitochondrial and Cellular Health Supplement

New York City, April 22, 2025 (GLOBE NEWSWIRE) -- The recent energy drops together with slowing metabolic processes and cognitive decline present a common problem that the pioneering solution Mitolyn addresses to rejuvenate cellular health alongside …

UPDATE -- AP Biosciences to Present New Preclinical Data at American Association of Cancer Research Annual Meeting

UPDATE -- AP Biosciences to Present New Preclinical Data at American Association of Cancer Research Annual Meeting

TAIPEI, Taiwan, April 21, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical abstract in …

UPDATE -- Opreme Films announces “Just Blood”: A Medical Demonstration Poised to Rewrite Theranos Story

UPDATE -- Opreme Films announces “Just Blood”: A Medical Demonstration Poised to Rewrite Theranos Story

MIAMI BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- In a moment destined to shake the foundation of modern medicine—and perhaps the U.S. justice system—visionary medical innovator Ryan El-Hosseiny is making a bold and unprecedented claim: Elizabeth …

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China

HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in  …

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported that it received notice from the NYSE …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service